A Randomized, Data Collection Program To Determine the Efficacy and Safety of Risedronate (Actonel) Therapy Plus Calcium and Vitamin D Supplementation Versus Placebo Plus Calcium and Vitamin D Supplementation in the Treatment of Low Bone Mineral Density in Crohn's Disease Patients.
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2010
At a glance
- Drugs Risedronic acid (Primary)
- Indications Bone resorption; Osteoporosis
- Focus Therapeutic Use
- 12 Oct 2010 New trial record